Simple jQuery Dropdowns

Browsing by Author Ege University Medical School

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)
1-Jan-2020Changing patterns in the epidemiology of β-thalassemiaAntonis Kattamis; Gian Luca Forni; Yesim Aydinok; Vip Viprakasit; National and Kapodistrian University of Athens; E.O. Ospedali Galliera; Faculty of Medicine, Siriraj Hospital, Mahidol University; Ege University Medical School
1-Jan-2011Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overloadDudley J. Pennell; John B. Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi Kong Li; Vip Viprakasit; Mohsen Saleh Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher; Royal Brompton Hospital; UCL; Universita degli Studi di Milano; University of Malaya Medical Centre; Cairo University; Ege University Medical School; Kuala Lumpur Hospital; Prince of Wales Hospital Hong Kong; Mahidol University; Ain Shams University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; American University of Beirut
1-Jan-2014Current approach to iron chelation in childrenYesim Aydinok; Antonis Kattamis; Vip Viprakasit; Ege University Medical School; University of Athens Medical School; Mahidol University
18-Jun-2015Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overloadYesim Aydinok; Antonis Kattamis; M. Domenica Cappellini; Amal El-Beshlawy; Raffaella Origa; Mohsen Elalfy; Yurdanur Kilinç; Silverio Perrotta; Zeynep Karakas; Vip Viprakasit; Dany Habr; Niculae Constantinovici; Junwu Shen; John B. Porter; Ege University Medical School; University of Athens; Universita degli Studi di Milano; Cairo University; Universita degli Studi di Cagliari; Ain Shams University; Cukurova Universitesi; Child and of General and Specialist Surgery; Istanbul Tip Fakultesi; Mahidol University; Novartis Pharmaceuticals; Novartis International AG; UCL Cancer Institute
11-Jan-2018Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a studyAli T. Taher; Zeynep Karakas; Elena Cassinerio; Noppadol Siritanaratkul; Antonis Kattamis; Aurelio Maggio; Stefano Rivella; Norbert Hollaender; Bruyere Mahuzier; Brian Gadbaw; Yesim Aydinok; American University of Beirut Medical Center; Università degli Studi di Milano; The Children's Hospital of Philadelphia; National and Kapodistrian University of Athens; Novartis Pharma S.A.S.; Istanbul Üniversitesi Tıp Fakültesi; Faculty of Medicine, Siriraj Hospital, Mahidol University; Novartis International AG; Ege University Medical School; Novartis Pharmaceuticals Corporation; UOSD MICI-A.O. Ospedali Riuniti “Villa Sofia-Cervello” Palermo
13-Nov-2019Genome-wide Association Study Identifies Genetic Variants Associated with Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B StudyWillem P. Brouwer; Henry L.Y. Chan; Pietro Lampertico; Jinlin Hou; Pisit Tangkijvanich; Hendrik W. Reesink; Wenhong Zhang; Alessandra Mangia; Tawesak Tanwandee; Giuseppe Montalto; Kris Simon; Necati Ormeci; Liang Chen; Fehmi Tabak; Fulya Gunsar; Robert Flisiak; Peter Ferenci; Meral Akdogan; Filiz Akyuz; Nattiya Hirankarn; Louis Jansen; Vincent Wai Sun Wong; Roberta Soffredini; Xieer Liang; Shalom Chen; Zwier M.A. Groothuismink; Rosanna Santoro; Jerzy Jaroszewicz; Resat Ozaras; Karin Kozbial; Mayur Brahmania; Qing Xie; Watcharasak Chotiyaputta; Qi Xun; Monika Pazgan-Simon; Erkin Oztas; Elke Verhey; Noé R. Montanari; Jian Sun; Bettina E. Hansen; Andre Boonstra; Harry L.A. Janssen; Bettina Hansen; Harry Janssen; Heng Chi; Milan Sonneveld; Rob De Knegt; Henry Chan; Vincent Wong; Grace Wong; Pietro Lampertico; Marta Borghi; Alessandro Loglio; Jinlin Hou; Jian Sun; Xieer Liang; Pisit Tangkijvanich; Nattiya Hirankarn; Pimpayao Sodsai; Natthaya Chuaypen; Henk Reesink; Wenhong Zhang; Shalom Chen; Alessandra Mangia; Rosanna Santoro; Guiseppe Montalto; Kris Simon; Liang Chen; Xi Qun; Robert Flisiak; Jerzy Jaroszewicz; Peter Ferenci; Erkin Oztas; Filiz Akyuz; Jordan Feld; Seham Noureldin; Simin Guo; Qing Xie; Shanghai Jiao Tong University School of Medicine; IRCCS Casa Sollievo della Sofferenza; Erasmus MC; Università degli Studi di Milano; Chulalongkorn University; Slaski Uniwersytet Medyczny w Katowicach; Uniwersytet Medyczny w Bialymstoku; Toronto General Hospital; Università degli Studi di Palermo; Ankara Üniversitesi; Istanbul Üniversitesi Tıp Fakültesi; Medizinische Universitat Wien; Faculty of Medicine, Siriraj Hospital, Mahidol University; Fudan University; Ege University Medical School; Wroclaw Medical University; Chinese University of Hong Kong; Amsterdam UMC - University of Amsterdam; Yuksek Ihsitas Hospital; Cerrahpasa Medical Faculty; Southern Medical University
1-Mar-2016Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS studyAli T. Taher; M. Domenica Cappellini; Yesim Aydinok; John B. Porter; Zeynep Karakas; Vip Viprakasit; Noppadol Siritanaratkul; Antonis Kattamis; Candace Wang; Zewen Zhu; Victor Joaquin; Marie José Uwamahoro; Yong Rong Lai; American University of Beirut Medical Center; Università degli Studi di Milano; Ege University Medical School; UCL; Istanbul Tip Fakultesi; Mahidol University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; Guangxi Medical University
5-Apr-2012A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overloadEllis J. Neufeld; Renzo Galanello; Vip Viprakasit; Yesim Aydinok; Antonio Piga; Paul Harmatz; Gian Luca Forni; Farrukh T. Shah; Rachael F. Grace; John B. Porter; John C. Wood; Jennifer Peppe; Amber Jones; Hugh Young Rienhoff; Harvard University; Universita degli Studi di Cagliari; Mahidol University; Ege University Medical School; Scienze Cliniche e Biologiche; UCSF Benioff Children's Hospital Oakland; E.O. Ospedali Galliera; Whittington Hospital; UCL; Children's Hospital Los Angeles; FerroKin BioSciences, Inc.
26-Mar-2020A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemiaM. Domenica Cappellini; Vip Viprakasit; Ali T. Taher; Pencho Georgiev; Kevin H.M. Kuo; Thomas Coates; Ersi Voskaridou; Hong Keng Liew; Idit Pazgal-Kobrowski; G. L. Forni; Silverio Perrotta; Abderrahim Khelif; Ashutosh Lal; Antonis Kattamis; Efthymia Vlachaki; Raffaella Origa; Yesim Aydinok; Mohamed Bejaoui; P. Joy Ho; Lee Ping Chew; Ping Chong Bee; Soo Min Lim; Meng Yao Lu; Adisak Tantiworawit; Penka Ganeva; Liana Gercheva; Farrukh Shah; Ellis J. Neufeld; Alexis Thompson; Abderrahmane Laadem; Jeevan K. Shetty; Jun Zou; Jennie Zhang; Dimana Miteva; Tatiana Zinger; Peter G. Linde; Matthew L. Sherman; Olivier Hermine; John Porter; Antonio Piga; l'Institut des Maladies Génétiques Imagine; Azienda Ospedaliera Brotzu - Microcitemico; Centre National de Greffe de Moelle Osseuse; University Hospital St. Marina; American University of Beirut Medical Center; Hopital Farhat Hached Sousse; UCSF Benioff Children‘s Hospital; Università degli Studi di Milano; National and Kapodistrian University of Athens; St.George University Hospital; Hôpital Necker Enfants Malades; Università degli Studi della Campania Luigi Vanvitelli; Laikon General Hospital; UCL; Rabin Medical Center Israel; St. Jude Children's Research Hospital; Celgene Corporation; E.O. Ospedali Galliera; Royal Prince Alfred Hospital; University of Toronto; Keck School of Medicine of USC; University of Malaya Medical Centre; Hospital Sultanah Aminah; Università degli Studi di Torino; Faculty of Medicine, Siriraj Hospital, Mahidol University; Ege University Medical School; National Health Service; National Taiwan University; Hippokration General Hospital; Chiang Mai University; Celgene; Hospital Umum; Ann and Robert H. Lurie Children's Hospital of Chicago; Specialized Hospital for Active Treatment in Oncology; Hospital Sultanah Bahiyah; Acceleron Pharma
1-Jan-2012Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: A randomized controlled trialErich V. de Paula; Kaan Kavakli; Johnny Mahlangu; Yasmin Ayob; Steven R. Lentz; Massimo Morfini; László Nemes; Silva Z. Šalek; Midori Shima; Jerzy Windyga; Silke Ehrenforth; Ampaiwan Chuansumrit; Universidade Estadual de Campinas; Ege University Medical School; Academic Hospital; National Blood Center; University of Iowa; Azienda Ospedaliera Careggi; National Hemophilia Center; University of Zagreb School of Medicine; Nara Kenritsu Ika Daigaku Fozuku Byoin; Institute of Haematology and Transfusion Medicine, Warsaw; Novo Nordisk AS; Mahidol University
1-Jan-2013Vaccine for prevention of mild and moderate-to-severe influenza in childrenVarsha K. Jain; Luis Rivera; Khalequ Zaman; Roberto A. Espos; Chukiat Sirivichayakul; Beatriz P. Quiambao; Doris M. Rivera-Medina; Pirunghul Kerdpanich; Mehmet Ceyhan; Ener C. Dinleyici; Alejandro Cravioto; Mohammed Yunus; Pornthep Chanthavanich; Kriengsak Limkittikul; Zafer Kurugol; Emre Alhan; Adrian Caplanusi; Serge Durviaux; Philippe Boutet; Opokua Ofori-Anyinam; Vijayalakshmi Chandrasekaran; Ghassan Dbaibo; Bruce L. Innis; GlaxoSmithKline, USA; Hospital Maternidad Nuestra Señora de la Altagracia; International Centre for Diarrhoeal Disease Research Bangladesh; De La Salle Health Sciences Institute; Gokila; Mahidol University; Royal Thai Army; Organización para el Desarrollo y la Investigación Salud en Honduras (ODISH); Hacettepe Universitesi; Eskisehir Osmangazi Universitesi Tip Fakultesi; Ege University Medical School; Cukurova Universitesi; GlaxoSmithKline Pharmaceuticals SA; American University of Beirut Medical Center